Rockwell Medical, Inc. (RMTI)

NASDAQ: RMTI · Real-Time Price · USD
4.020
+0.080 (2.03%)
At close: Sep 18, 2024, 4:00 PM
3.906
-0.114 (-2.83%)
After-hours: Sep 18, 2024, 5:03 PM EDT
2.03%
Market Cap 124.74M
Revenue (ttm) 94.37M
Net Income (ttm) -4.92M
Shares Out 31.03M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE 114.86
Dividend n/a
Ex-Dividend Date n/a
Volume 477,204
Open 3.940
Previous Close 3.940
Day's Range 3.880 - 4.120
52-Week Range 1.160 - 4.380
Beta 1.47
Analysts Strong Buy
Price Target 7.00 (+74.13%)
Earnings Date Nov 12, 2024

About RMTI

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products,... [Read more]

Sector Healthcare
IPO Date Jan 27, 1998
Employees 237
Stock Exchange NASDAQ
Ticker Symbol RMTI
Full Company Profile

Financial Performance

In 2023, Rockwell Medical's revenue was $83.61 million, an increase of 14.84% compared to the previous year's $72.81 million. Losses were -$8.59 million, -54.02% less than in 2022.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for RMTI stock is "Strong Buy." The 12-month stock price forecast is $7.0, which is an increase of 74.13% from the latest price.

Price Target
$7.0
(74.13% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production'

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Great Place to Work and Fortune magazine selected Rockwell Medical for the 2024 Fortune Best Workplaces in Manufacturing and Production ...

11 hours ago - Business Wire

Rockwell Medical: The Turnaround Is Looking Real

Rockwell develop concentrates for hemodialysis, which is a process that seeks to artificially replace kidney function in patients with chronic failure. Despite being a critical product, there's curren...

3 days ago - Seeking Alpha

Rockwell Medical Announces Product Purchase Agreement with Leading At-Home and Acute Care Dialysis Provider

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces a product purchase agreement with the leading at-home and acute care dialysis provider in the United States.

9 days ago - Business Wire

Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript

5 weeks ago - Seeking Alpha

Rockwell Medical Reports Profitability on a Cash Flow and Adjusted EBITDA Basis in the Second Quarter of 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced financial and operational results for the three and six months ended June 30, 2024.

5 weeks ago - Business Wire

Rockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis Facilities

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Convenience Pack offers a number of advantages for home hemodialysis patients and acute care dialysis facilities.

6 weeks ago - Business Wire

Rockwell Medical Looks Like A Speculative Buy As It Approaches Profitability

Rockwell is a microcap manufacturer of hemodialysis concentrates for kidney failure patients, trading at under 1x full-year 2023 revenue. The company has a significant market opportunity with the grow...

2 months ago - Seeking Alpha

Rockwell Medical to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's president and CEO, Dr. Mark Strobeck, to present at the H.C. Wainwright 3rd Annual Kidney Conference.

2 months ago - Business Wire

Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the second quarter ended June 30, 2024 on Thursday, August 8, 20...

2 months ago - Business Wire

Rockwell Medical Promotes Tim Chole to Chief Commercial Officer

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Chole has played a key role in helping Rockwell Medical increase its market share and broaden its product portfolio.

3 months ago - Business Wire

Rockwell Medical, Inc. (RMTI) Q1 2024 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI) Q1 2024 Earnings Conference Call May 14, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President, Chief Corporate Affairs Officer Mark Strobec...

4 months ago - Seeking Alpha

Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical (Nasdaq: RMTI) today announced financial and operational results for the three months ended March 31, 2024.

4 months ago - Business Wire

Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into a new direct supply agreement with one of the largest health systems in the Mountain West Region of the Uni...

5 months ago - Business Wire

Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the first quarter ended March 31, 2024 on Tuesday, May 14, 2024.

5 months ago - Business Wire

Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into new and expanded distribution agreements with BioNuclear and Atlantic Medical International, respectively.

5 months ago - Business Wire

Rockwell Medical Named 'Great Place to Work' for Second Year in a Row

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work® for the second year in a row.

6 months ago - Business Wire

Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript

6 months ago - Seeking Alpha

Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...

6 months ago - Business Wire

Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2023 on Thursday, March 21, 2024.

7 months ago - Business Wire

Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Defers principal payments of $8M up to 3yrs, reduces Rockwell Medical's need for additional operating capital, and enhances the Company'...

9 months ago - Business Wire

Returning To Rockwell Medical: Buy At 65% Of Revenue

Rockwell Medical is arguably the strongest player in the hemodialysis market and a top 5 healthcare supplier per Seeking Alpha Quant. The Company still addresses a critical medical condition and has a...

10 months ago - Seeking Alpha

Rockwell Medical, Inc. (RMTI) Q3 2023 Earnings Call Transcript

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2023 Earnings Conference Call November 14, 2023 8:00 AM ET Company Participants Heather Hunter - SVP & Chief Corporate Affairs Officer Mark Strobeck - Presiden...

11 months ago - Seeking Alpha

Rockwell Medical Announces Third Quarter 2023 Results

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...

11 months ago - Business Wire

Rockwell Medical Names Jesse Neri as Senior Vice President, Finance

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Jesse Neri has 20+ years' experience leading finance functions at both public and private companies.

1 year ago - Business Wire

Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Dr. Joan Lau brings 20+ years of experience as an entrepreneur scientist, CEO, operator, investor, and board member of public and privat...

1 year ago - Business Wire